Genotype study makes its point

Data published in Nature Genetics by scientists at Genset S.A. (Paris, France) and partner Abbott Laboratories (Abbott Park, Ill.) suggests a predictive role for the ALOX5 genotype in managing asthma.

The research effectively shows proof of principle for the pharmacogenomics strategy of analyzing the effects of genetic variations on patient response. However, Genset (NM:Genset; GENXY) considers the finding to be a piece of a bigger puzzle, and has no plans to commercialize an ALOX5 diagnostic...